BUENOS AIRES--(BUSINESS WIRE)--GridX, Latin America's largest biotechnology investment fund and company builder, is set to begin its international Roadshow featuring 21 innovative startups across ...

GridX, Latin America’s largest biotechnology investment fund and company builder, is set to begin its international Roadshow featuring 21 innovative startups across three strategic U.S. cities ...

As the world enters an age of biotechnology, there is emerging evidence that China is “distorting” biotechnology markets and is quickly ascending to “dominance” in this field, having made ...

One relatively small biotech company has made a breakthrough that could be used to treat a range of cancer. While it's been a poor performer for the past few years despite promising growth ...

Passed by the House in September 2024, the Biosecure Act took a particularly hardline stance on Chinese biotech, denying top firms access to U.S. pharma supply chains. The bill forced U.S ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Ardelyx Inc. (NASDAQ:ARDX) stands against ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where ORIC Pharmaceuticals Inc. (NASDAQ ...

I often refer to Regeneron as a “Biotech Juggernaut” because it seems like they have similar strengths to the comic book character. The company appears to have unstoppable momentum thanks to a ...

After San Francisco biotech company Third Harmonic Bio slashed its staff by half in February, it’s now taking a more drastic step. The inflammatory disease research company’s directors have ...

One such contender is Syntis Bio, a Boston-based biotech firm working on an oral medication designed to replicate the effects of gastric bypass surgery without the need for invasive procedures.

Viking Therapeutics Inc (NASDAQ:VKTX) stock is up 10.1% to trade at $24.42 today, and traded as high as $27.09 earlier in the session. The drugmaker is on the move after Pfizer (PFE) halted the ...

Analysis-Trump Health Policy Uncertainty Sends Biotech Sector Into Deeper Slump By Maggie Fick and Bhanvi Satija LONDON (Reuters) -Trump administration cuts across federal health agencies have ...